Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Germino FW – The present analysis of pooled data from 2 previously published registration studies found that nebivolol was associated with significant reductions in BP compared with placebo in these patients with stage 1 or 2 hypertension, with a tolerability similar to that of placebo.
Related Articles
Nebivolol in High-Risk, Obese African Americans With Stage 1 Hypertension: Effects on Blood Pressure, Vascular Compliance, and Endothelial Function
The Journal of Clinical Hypertension, 10/12/09
Relevance Score: 69%
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 47%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 46%
Hypertension in Women: More Evidence for the Role of Lifestyle
Nursing for Women's Health, 10/12/09
Relevance Score: 46%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 46%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


